This clearly shows that ST, while inducing dramatic changes in Tau phosphorylation, does not trigger any neuroinflammatory response within the SpCo, this being considered an important factor in neurodegenerative diseases (Ransohoff, 2016; Nilson et al., 2017). Here, MAPT is linked to neurodegenerative disease.